CN110859258A - 一种沙棘油乳及其制备方法 - Google Patents
一种沙棘油乳及其制备方法 Download PDFInfo
- Publication number
- CN110859258A CN110859258A CN201911145628.XA CN201911145628A CN110859258A CN 110859258 A CN110859258 A CN 110859258A CN 201911145628 A CN201911145628 A CN 201911145628A CN 110859258 A CN110859258 A CN 110859258A
- Authority
- CN
- China
- Prior art keywords
- oil emulsion
- sea
- sucralose
- parts
- purified water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000003145 Hippophae rhamnoides Nutrition 0.000 title claims abstract description 79
- 239000000839 emulsion Substances 0.000 title claims abstract description 68
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000004945 emulsification Methods 0.000 title description 2
- 240000000950 Hippophae rhamnoides Species 0.000 title 1
- 241000229143 Hippophae Species 0.000 claims abstract description 99
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims abstract description 32
- 235000019408 sucralose Nutrition 0.000 claims abstract description 32
- 239000004376 Sucralose Substances 0.000 claims abstract description 31
- 230000001954 sterilising effect Effects 0.000 claims abstract description 31
- 239000008213 purified water Substances 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 210000003022 colostrum Anatomy 0.000 claims abstract description 26
- 235000021277 colostrum Nutrition 0.000 claims abstract description 26
- 238000011049 filling Methods 0.000 claims abstract description 19
- 239000007864 aqueous solution Substances 0.000 claims abstract description 17
- 238000004806 packaging method and process Methods 0.000 claims abstract description 13
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 12
- 238000007865 diluting Methods 0.000 claims abstract description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 23
- 235000003935 Hippophae Nutrition 0.000 claims description 20
- 239000003085 diluting agent Substances 0.000 claims description 18
- 238000002372 labelling Methods 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 12
- 229920001615 Tragacanth Polymers 0.000 claims description 7
- 238000003860 storage Methods 0.000 claims description 7
- 239000000084 colloidal system Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000007689 inspection Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 5
- 230000007480 spreading Effects 0.000 claims description 5
- 238000003892 spreading Methods 0.000 claims description 5
- 235000010489 acacia gum Nutrition 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 229920000084 Gum arabic Polymers 0.000 claims description 3
- 239000000205 acacia gum Substances 0.000 claims description 3
- 239000000305 astragalus gummifer gum Substances 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 235000013361 beverage Nutrition 0.000 abstract description 2
- 235000019198 oils Nutrition 0.000 description 55
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 241000220479 Acacia Species 0.000 description 5
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- 241000416162 Astragalus gummifer Species 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- 235000021319 Palmitoleic acid Nutrition 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 4
- 230000000975 bioactive effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 235000021466 carotenoid Nutrition 0.000 description 4
- 150000001747 carotenoids Chemical class 0.000 description 4
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- 229960004488 linolenic acid Drugs 0.000 description 4
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- 235000010487 tragacanth Nutrition 0.000 description 4
- 239000000196 tragacanth Substances 0.000 description 4
- 229940116362 tragacanth Drugs 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 229930003448 Vitamin K Natural products 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 235000019168 vitamin K Nutrition 0.000 description 3
- 239000011712 vitamin K Substances 0.000 description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 229940046010 vitamin k Drugs 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- -1 and protecting liver Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- IOSXSVZRTUWBHC-LBTVDEKVSA-N Quassin Chemical compound CC([C@@H]1CC(=O)O[C@@H]([C@]21C)C1)=C(OC)C(=O)[C@@H]2[C@]2(C)[C@@H]1[C@H](C)C=C(OC)C2=O IOSXSVZRTUWBHC-LBTVDEKVSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000023819 chronic asthma Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229940064302 folacin Drugs 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- IOSXSVZRTUWBHC-UHFFFAOYSA-N quassin Natural products C1C(C23C)OC(=O)CC3C(C)=C(OC)C(=O)C2C2(C)C1C(C)C=C(OC)C2=O IOSXSVZRTUWBHC-UHFFFAOYSA-N 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及饮品及其制备方法，具体是指一种沙棘油乳及其制备方法，其配方包括下述重量份的成分：沙棘油35‑45份、纯化水18‑25份、乳化剂8‑12份、三氯蔗糖水溶液114‑143份；其方法包括制备初乳、稀释初乳、灌装、灭菌、检验包装等步骤。本发明制成的沙棘油乳口感好、色泽纯正，保留了沙棘油中的原有成分，同时掩盖了沙棘油的不良气味，有利于人体吸收，提高了沙棘油的生物利用度。
Description
技术领域
本发明涉及饮品及其制备方法，特别涉及一种沙棘油乳及其制备方法。
背景技术
沙棘油是从天然植物沙棘的果实当中提取出来的天然的油脂，含有不饱和脂肪酸、黄酮、维生素、微量元素等一百多种生物活性物质，可以降低高血脂、软化血管、降低低密度脂蛋白、升高高密度脂蛋白、清除血管壁沉积物、磷脂能促进脂质转运和清除、加速血液中甘油三酯的代谢及防治动脉粥样硬化的形成，具有调节胃肠功能、保护肝脏、降血压、降血脂、保护血管、滋养心脑血管、增强心脏功能、滋补肝肾、养颜抗衰老等作用。沙棘籽油为透明浅黄色液体，口服口感较差，不被大多数人所接受，因此食用受到很大限制。此外，沙棘油服用量少，在胃内分散度差，不利于人体吸收。
发明内容
针对现有技术中的上述不足，本发明提供了一种沙棘油乳及其制备方法，其口感好、色泽纯正。
为了达到上述发明目的，本发明采用的技术方案为：
一种沙棘油乳，包括下述重量份的成分：沙棘油35-45份、纯化水18-25份、乳化剂8-12份、三氯蔗糖水溶液114-143份。
作为优选的，所述乳化剂为细粉形式，所述乳化剂为阿拉伯胶或黄蓍胶中的一种或两种混合。
作为优选的，所述三氯蔗糖水溶液的浓度为0.003％-0.025％。
一种沙棘油乳的制备方法，包括如下步骤：
(1)制备初乳：取沙棘油置于干燥的均质搅拌机中，将乳化剂撒在沙棘油的表面，充分浸润后加入纯化水，开启均质搅拌机均质制得初乳，再将初乳置胶体磨中进一步乳化，形成稠厚的初乳；
(2)稀释初乳：将初乳转移至配料罐中进行搅拌，把三氯蔗糖在50-60℃的纯化水中溶解后加入初乳中，加入三氯蔗糖纯化水溶液后，沙棘油含量约为20％，开启搅拌器搅拌均匀，拌器搅转速为1300-1500r/min，搅拌时间约为15分钟；将搅拌均匀的稀释液通过均质机进一步均质，均质后经过滤器过滤，输送到储料罐中备用；
(3)灌装：将沙棘油乳通过管道输送至灌装机，按规格要求进行灌装；
(4)灭菌：将灌装后的沙棘油乳置于旋转式纯化水浴灭菌柜中进行灭菌，灭菌温度121℃，灭菌时间15分钟，灭菌后进行甩干、冷却、晾干；
(5)检验包装：灭菌后的产品送化验室进行检验，检验合格后进行包装，置贴标机贴标后装箱。
作为优选的，所述三氯蔗糖水溶液的制备方法为：将适量的三氯蔗糖加入50-60℃的纯化水中，溶解即得。
本发明的有益效果为：制成的沙棘油乳口感好、色泽纯正，保留了沙棘油中的原有成分，同时掩盖了沙棘油的不良气味，有利于人体吸收，提高了沙棘油的生物利用度。
具体实施方式
为了使本发明的内容更容易被清楚地理解，下面将对本发明实施例中的技术方案进行清楚、完整地描述。
沙棘油是沙棘的精华，医学临床表明，沙棘总黄酮可以降低高血脂、软化血管。并降低低密度脂蛋白，升高高密度脂蛋白，清除血管壁沉积物，磷脂能促进脂质转运和清除，加速血液中甘油三酯的代谢。防治动脉粥样硬化的形成。由于沙棘中含有大量的氨基酸、有机酸等多种营养成分，可以促进胃酸的生物合成，刺激胃液分泌。因而沙棘具有消食化滞、健脾养胃、疏肝理气的作用。对于消化不良、腹胀痛、胃炎、胃及十二指肠溃疡、肠炎、慢性便秘均有极好作用。沙棘中含有的苹果酸、草酸等有机酸具有缓解抗生素和其他药物的毒性作用，保护肝脏，赖氨酸是肝细胞再生剂。沙棘中的磷酯类化合物是一种生物活性较高的成分，可促进细胞代谢，改善肝功能，抗脂肪肝，抗肝硬化。沙棘中的生物活性成分花青素、苦木素、香豆素、5-羟色胺等可阻断黄曲霉菌等致癌物质或病菌的侵害，具有明显辅助抑制癌细胞生长的作用。沙棘总黄酮等生物活性成分对免疫系统的多环节具有不同程度的调节能力，对体液免疫和细胞免疫具有明显的调节作用。沙棘在传统医学理论中就具有止咳平喘、利肺化痰的作用，对慢性咽炎、支气管炎、咽喉肿痛、哮喘、咳嗽多痰等呼吸道系统疾病均有很好作用。
沙棘果油中含有丰富的不饱和脂肪酸、蛋白质。其中所含的20多种氨基酸中，包括8种人体必须氨基酸。其最优异植物类不饱和脂肪酸含量为88％，并富含叶酸，叶酰胺元素，5-羟色胺，生物硷等106种生物活性物质。经科学实验证明，对滋养心脑血管、软化血管、防止动脉粥样硬化、血栓形成,增强心脏功能、降低血脂、调节血压、滋补肝肾、养颜抗衰老有着不寻常的功效作用。
一种沙棘油乳，包括下述重量份的成分：沙棘油35-45份、纯化水18-25份、乳化剂8-12份、三氯蔗糖水溶液114-143份。
作为优选的，所述乳化剂为细粉形式，所述乳化剂为阿拉伯胶或黄蓍胶中的一种或两种混合。
作为优选的，所述三氯蔗糖水溶液的浓度为0.003％-0.025％。
一种沙棘油乳的制备方法，包括如下步骤：
(1)制备初乳：取沙棘油置于干燥的均质搅拌机中，将乳化剂撒在沙棘油的表面，充分浸润后加入纯化水，开启均质搅拌机均质制得初乳，再将初乳置胶体磨中进一步乳化，形成稠厚的初乳；
(2)稀释初乳：将初乳转移至配料罐中进行搅拌，并加入三氯蔗糖纯化水溶液，开启搅拌器搅拌均匀，拌器搅转速为1300-1500r/min，搅拌时间约为15分钟；将搅拌均匀的稀释液通过均质机进一步均质，均质后经过滤器过滤，输送到储料罐中备用；
(3)灌装：将沙棘油乳通过管道输送至灌装机，按规格要求进行灌装；
(4)灭菌：将灌装后的沙棘油乳置于旋转式纯化水浴灭菌柜中进行灭菌，灭菌温度121℃，灭菌时间15分钟，灭菌后进行甩干、冷却、晾干；
(5)检验包装：灭菌后的产品送化验室进行检验，检验合格后进行包装，置贴标机贴标后装箱。
作为优选的，所述三氯蔗糖水溶液的制备方法为：将适量的三氯蔗糖加入50-60℃的纯化水中，溶解即得。
本发明的感官指标：
乳白色不透明液体，均匀一致，无杂质，久置后无分层沉淀；无异味，甜度适口。
本发明的理化指标：
饱和脂肪酸：
硬脂酸0.2-0.5％；
不饱和脂肪酸：
棕榈烯酸≥1.36％，
油酸≥4.0％，
亚油酸≥6.5％，
亚麻酸≥5.4％，
植物甾醇220-260mg/100g，
不皂化物0.2-0.7％；
维生素：
类胡萝卜素≥10万IU/100g，
维生素E≥14IU/100g，
维生素K≥24mg/100g，
维生素A≥4.6万IU/100g；
微量元素：
铁0.11-0.25mg/100g，
锌0.04-0.12mg/100g，
钙0.17-0.25mg/100g，
碘3.66-4.50ug/100g。
本发明的有益效果为：制成的沙棘油乳口感好、色泽纯正，保留了沙棘油中的原有成分，同时掩盖了沙棘油的不良气味，有利于人体吸收，提高了沙棘油的生物利用度。
实施例一：
一种沙棘油乳，包括下述重份的成分：沙棘油400g、纯化水200g、阿拉伯胶80g、黄蓍胶20g、0.005％三氯蔗糖水溶液1300g。
一种沙棘油乳的制备方法，包括如下步骤：
(1)制备初乳：取400g沙棘油置于干燥的均质搅拌机中，将80g阿拉伯胶、20g黄蓍胶撒在沙棘油的表面，充分浸润后沙棘油加入200g纯化水，开启均质搅拌机均质制得初乳，再将初乳置胶体磨中进一步乳化，形成稠厚的初乳；
(2)稀释初乳：将初乳转移至配料罐中进行搅拌，把0.065g三氯蔗糖在1300g的55℃的纯化水中溶解后加入初乳中，加入三氯蔗糖水溶液后，初乳中的沙棘油含量为20％，此时开启搅拌器搅拌均匀，拌器搅转速为1300-1500r/min，搅拌时间约为15分钟；将搅拌均匀的稀释液通过均质机进一步均质，均质后经过滤器过滤，输送到储料罐中备用；
(3)灌装：将沙棘油乳通过管道输送至灌装机，按规格要求进行灌装；
(4)灭菌：将灌装后的沙棘油乳置于旋转式纯化水浴灭菌柜中进行灭菌，灭菌温度121℃，灭菌时间15分钟，灭菌后进行甩干、冷却、晾干；
(5)检验包装：灭菌后的产品送化验室进行检验，检验合格后进行包装，置贴标机贴标后装箱。
本实施例制出的成品沙棘油乳的理化指标为：硬脂酸0.35％；棕榈烯酸1.45％，油酸4.2％，亚油酸6.6％，亚麻酸5.8％，植物甾醇230mg/100g，不皂化物0.25％；类胡萝卜素15万IU/100g，维生素E15IU/100g，维生素K 26mg/100g，维生素A5.2万IU/100g；铁0.20mg/100g，锌0.045mg/100g，钙0.185mg/100g，碘3.8ug/100g。
实施例二：
一种沙棘油乳，包括下述重份的成分：沙棘油450g、纯化水220g、阿拉伯胶110g、0.025％三氯蔗糖水溶液1270g。
一种沙棘油乳的制备方法，包括如下步骤：
(1)制备初乳：取450g沙棘油置于干燥的均质搅拌机中，将110g阿拉伯胶撒在沙棘油的表面，充分浸润后沙棘油加入220g纯化水，开启均质搅拌机均质制得初乳，再将初乳置胶体磨中进一步乳化，形成稠厚的初乳；
(2)稀释初乳：将初乳转移至配料罐中进行搅拌，把0.3175g三氯蔗糖在1270g的58℃的纯化水中溶解后加入初乳中，加入三氯蔗糖水溶液后，初乳中的沙棘油含量约为22％，此时开启搅拌器搅拌均匀，拌器搅转速为1300-1500r/min，搅拌时间约为15分钟；将搅拌均匀的稀释液通过均质机进一步均质，均质后经过滤器过滤，输送到储料罐中备用；
(3)灌装：将沙棘油乳通过管道输送至灌装机，按规格要求进行灌装；
(4)灭菌：将灌装后的沙棘油乳置于旋转式纯化水浴灭菌柜中进行灭菌，灭菌温度121℃，灭菌时间15分钟，灭菌后进行甩干、冷却、晾干；
(5)检验包装：灭菌后的产品送化验室进行检验，检验合格后进行包装，置贴标机贴标后装箱。
本实施例制出的成品沙棘油乳的理化指标为：硬脂酸0.3％；棕榈烯酸1.38％，油酸4.2％，亚油酸7.0％，亚麻酸5.8％，植物甾醇220mg/100g，不皂化物0.4％；类胡萝卜素14万IU/100g，维生素E14IU/100g，维生素K 25mg/100g，维生素A 5万IU/100g；铁0.21mg/100g，锌0.045mg/100g，钙0.18mg/100g，碘3.75ug/100g。
实施例三：
一种沙棘油乳，包括下述重份的成分：沙棘油350g、纯化水180g、阿拉伯胶20g、黄蓍胶70g、0.015％三氯蔗糖水溶液1380g。
一种沙棘油乳的制备方法，包括如下步骤：
(1)制备初乳：取350g沙棘油置于干燥的均质搅拌机中，将20g阿拉伯胶、70g黄蓍胶撒在沙棘油的表面，充分浸润后沙棘油加入180g纯化水，开启均质搅拌机均质制得初乳，再将初乳置胶体磨中进一步乳化，形成稠厚的初乳；
(2)稀释初乳：将初乳转移至配料罐中进行搅拌，把0.207g三氯蔗糖在1380g的58℃的纯化水中溶解后加入初乳中，加入三氯蔗糖水溶液后，初乳中的沙棘油含量为17.5％，此时开启搅拌器搅拌均匀，拌器搅转速为1300-1500r/min，搅拌时间约为15分钟；将搅拌均匀的稀释液通过均质机进一步均质，均质后经过滤器过滤，输送到储料罐中备用；
(3)灌装：将沙棘油乳通过管道输送至灌装机，按规格要求进行灌装；
(4)灭菌：将灌装后的沙棘油乳置于旋转式纯化水浴灭菌柜中进行灭菌，灭菌温度121℃，灭菌时间15分钟，灭菌后进行甩干、冷却、晾干；
(5)检验包装：灭菌后的产品送化验室进行检验，检验合格后进行包装，置贴标机贴标后装箱。
本实施例制出的成品沙棘油乳的理化指标为：硬脂酸0.35％；棕榈烯酸1.4％，油酸4.2％，亚油酸6.8％，亚麻酸6.1％，植物甾醇235mg/100g，不皂化物0.4％；类胡萝卜素13万IU/100g，维生素E14.5IU/100g，维生素K 26mg/100g，维生素A 5万IU/100g；铁0.18mg/100g，锌0.04mg/100g，钙0.175mg/100g，碘3.7ug/100g。
请50人分别对综合实施例一、实施例二、实施例三的成品沙棘油乳从外观、质地、口感方向进行感官测评，实施例一、实施例二、实施例三所得成品均为乳白色、均匀一致、无杂质、无异味的乳液；品尝后，34人认为实施例一制出的沙棘油乳口感最好，10人认为实施例二制出的沙棘油乳口感最好，6人认为实施例三制出的沙棘油乳口感最好；
结合理化指标的结果，得实施例一为本发明的最优配方。
以上所述仅为本发明专利的较佳实施例而已，并不用以限制本发明专利，凡在本发明专利的精神和原则之内所作的任何修改、等同替换和改进等，均应包含在本发明专利的保护范围之内。
Claims (5)
1.一种沙棘油乳，其特征在于，包括下述重量份的成分：沙棘油35-45份、纯化水18-25份、乳化剂8-12份、三氯蔗糖水溶液114-143份。
2.根据权利要求1所述的一种沙棘油乳，其特征在于：所述乳化剂为细粉形式，所述乳化剂为阿拉伯胶或黄蓍胶中的一种或两种混合。
3.根据权利要求1所述的一种沙棘油乳，其特征在于：所述三氯蔗糖水溶液的浓度为0.003％-0.025％。
4.一种沙棘油乳的制备方法，其特征在于，包括如下步骤：
(1)制备初乳：取沙棘油置于干燥的均质搅拌机中，将乳化剂撒在沙棘油的表面，充分浸润后加入纯化水，开启均质搅拌机均质制得初乳，再将初乳置胶体磨中进一步乳化，形成稠厚的初乳；
(2)稀释初乳：将初乳转移至配料罐中进行搅拌，把三氯蔗糖在50-60℃的纯化水中溶解后加入初乳中，加入三氯蔗糖纯化水溶液后，沙棘油含量约为20％，开启搅拌器搅拌均匀，拌器搅转速为1300-1500r/min，搅拌时间约为15分钟；将搅拌均匀的稀释液通过均质机进一步均质，均质后经过滤器过滤，输送到储料罐中备用；
(3)灌装：将沙棘油乳通过管道输送至灌装机，按规格要求进行灌装；
(4)灭菌：将灌装后的沙棘油乳置于旋转式纯化水浴灭菌柜中进行灭菌，灭菌温度121℃，灭菌时间15分钟，灭菌后进行甩干、冷却、晾干；
(5)检验包装：灭菌后的产品送化验室进行检验，检验合格后进行包装，置贴标机贴标后装箱。
5.根据权利要求4所述的一种沙棘油乳，其特征在于：所述三氯蔗糖水溶液的制备方法为：将适量的三氯蔗糖加入50-60℃的纯化水中，溶解即得。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911145628.XA CN110859258A (zh) | 2019-11-21 | 2019-11-21 | 一种沙棘油乳及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911145628.XA CN110859258A (zh) | 2019-11-21 | 2019-11-21 | 一种沙棘油乳及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110859258A true CN110859258A (zh) | 2020-03-06 |
Family
ID=69655770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911145628.XA Pending CN110859258A (zh) | 2019-11-21 | 2019-11-21 | 一种沙棘油乳及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110859258A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102166233A (zh) * | 2011-04-06 | 2011-08-31 | 西北农林科技大学 | 一种水包油型沙棘油纳米乳口服液及其制备方法 |
| CN103211761A (zh) * | 2013-04-07 | 2013-07-24 | 史小军 | 一种具有胃粘膜保护作用沙棘籽油口服乳剂及其制备方法和用途 |
| CN109122905A (zh) * | 2018-09-12 | 2019-01-04 | 江南大学 | 一种沙棘油纳米乳液的制备方法及沙棘油纳米乳液 |
| CN109430659A (zh) * | 2018-12-25 | 2019-03-08 | 哈尔滨氧态健康科技股份有限公司 | 一种牡丹籽油乳及其制备方法 |
-
2019
- 2019-11-21 CN CN201911145628.XA patent/CN110859258A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102166233A (zh) * | 2011-04-06 | 2011-08-31 | 西北农林科技大学 | 一种水包油型沙棘油纳米乳口服液及其制备方法 |
| CN103211761A (zh) * | 2013-04-07 | 2013-07-24 | 史小军 | 一种具有胃粘膜保护作用沙棘籽油口服乳剂及其制备方法和用途 |
| CN109122905A (zh) * | 2018-09-12 | 2019-01-04 | 江南大学 | 一种沙棘油纳米乳液的制备方法及沙棘油纳米乳液 |
| CN109430659A (zh) * | 2018-12-25 | 2019-03-08 | 哈尔滨氧态健康科技股份有限公司 | 一种牡丹籽油乳及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105613789B (zh) | 一种高脂高膳食纤维复合动植物粉末油脂、其制备方法及应用 | |
| CN105476020B (zh) | 一种维生素d3软胶囊及其制备方法 | |
| CN101946937B (zh) | 一种保健果汁饮料及其生产方法 | |
| CN109820079A (zh) | 一种咖啡燕窝饮料及其制备方法 | |
| CN103609695A (zh) | 降压祛火的酸奶及其制备方法 | |
| CN104256834A (zh) | 黑豆核桃露及其制备方法 | |
| CN106490508A (zh) | 一种具有健脾化湿功能的醋蛋液的制备方法 | |
| CN110859258A (zh) | 一种沙棘油乳及其制备方法 | |
| CN111685244A (zh) | 药食同源植物型饮料及其制备方法 | |
| CN111248290A (zh) | 一种山楂汁饮料浓浆及其生产工艺 | |
| CN108013382A (zh) | 一种醋蛋液及其制备方法 | |
| CN107006622A (zh) | 一种养生食用油及其制备方法 | |
| CN102763845A (zh) | 一种沙棘油蜂胶软胶囊 | |
| CN105995321A (zh) | 一种玫瑰茄复合果汁的加工方法 | |
| CN114391582A (zh) | 一种蛋白固体饮料及其制备方法 | |
| CN106578095A (zh) | 一种动植物蛋白固体饮料的制作方法 | |
| CN106479848A (zh) | 一种金花茶山楂酒 | |
| CN105685707A (zh) | 一种有助于婴儿消化的果汁 | |
| CN112352837A (zh) | 一种含不饱和脂肪酸的调制乳及其制备方法 | |
| CN104872753A (zh) | 一种亚麻(胡麻)小麦芽乳的生产方法 | |
| CN102920750A (zh) | 一种健脑明目保健复合制剂 | |
| CN104509898A (zh) | 一种含叶黄素的保健饮品 | |
| CN104187658B (zh) | 鸽保健口服液及其应用 | |
| KR19980072722A (ko) | 한약 조성물 | |
| CN115414433B (zh) | 一种具保健功效的植物油复方软胶囊及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200306 |
|
| RJ01 | Rejection of invention patent application after publication |